HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Plastic Surgery5 papers

Hepatic vein to right atrium

Last edited: 1 h ago

Overview

Hepatic vein to right atrium (HV-RA) anastomosis is a critical aspect of living-donor liver transplantation (LDLT), particularly concerning the right hepatic vein (RHV). This procedure ensures adequate venous outflow from the transplanted liver graft, preventing complications such as stenosis and graft failure. The complexity of RHV reconstruction in LDLT arises from the need to accommodate graft regeneration and potential alterations in anatomical positioning post-transplant. Proper HV-RA anastomosis is crucial for maintaining graft function and patient survival, making it a focal point in surgical technique refinement and clinical outcomes. Understanding and optimizing this anastomosis is essential for transplant surgeons to minimize complications and enhance long-term graft patency in daily practice 135.

Pathophysiology

The pathophysiology of complications related to HV-RA anastomosis primarily revolves around mechanical and hemodynamic factors. During LDLT, the intricate reconstruction of the RHV to the recipient's inferior vena cava (IVC) or right atrium can lead to stenosis due to tension, kinking, or inadequate outflow capacity. These issues often stem from mismatches in vein size, inadequate patching techniques, or suboptimal surgical anastomotic methods. Over time, these mechanical stresses can result in intimal hyperplasia and thrombosis, further compromising venous drainage. Additionally, graft regeneration post-transplant can alter the anatomical relationships, potentially exacerbating these issues if the initial anastomosis was not flexible enough to accommodate such changes. Effective management requires addressing both immediate surgical challenges and long-term hemodynamic stability to prevent chronic venous congestion and subsequent graft dysfunction 15.

Epidemiology

Epidemiological data specific to HV-RA anastomosis complications in LDLT are limited but suggest that right lobe grafts, which often involve complex RHV reconstruction, are particularly vulnerable. Studies indicate that the incidence of RHV stenosis ranges from 5% to 20% in LDLT recipients, with higher rates observed in smaller grafts or those requiring extensive venous reconstruction 1. Age, underlying liver disease severity, and graft-to-recipient weight ratio (GRWR) are recognized risk factors, with younger donors and recipients with lower GRWR theoretically benefiting from better outcomes. However, geographic and institutional variations in surgical techniques and patient selection criteria contribute to inconsistent prevalence figures across different regions and centers 23.

Clinical Presentation

Clinical presentation of HV-RA anastomosis complications typically manifests postoperatively, often within the first few weeks. Patients may exhibit signs of graft dysfunction, including elevated liver enzymes (AST, ALT), jaundice, ascites, and signs of portal hypertension such as variceal bleeding. Acute complications like graft thrombosis or stenosis can lead to rapid deterioration with symptoms like abdominal pain, fever, and hemodynamic instability. Chronic issues may present with gradual graft dysfunction, characterized by persistent biochemical abnormalities and impaired graft regeneration. Early recognition of these red-flag features is crucial for timely intervention and improved outcomes 13.

Diagnosis

The diagnostic approach for HV-RA anastomosis complications involves a combination of clinical assessment and imaging modalities. Key diagnostic criteria include:

  • Imaging Studies:
    • - Doppler Ultrasonography: Routine intraoperative and postoperative assessments (days 1-3) to evaluate patency and identify stenotic areas. - Computed Tomography (CT) Angiography: Performed on postoperative days 1, 7, 14, and at 1, 6, and 12 months to assess venous outflow, graft regeneration, and perfusion. - Venography: Indicated when Doppler findings suggest stenosis or non-opaque hepatic veins with luminal narrowing >50% compared to adjacent veins. - Manometry: Used to confirm pressure gradients >5 mm Hg across suspected stenotic areas.

  • Laboratory Tests:
    • - Elevated levels of AST, ALT, and bilirubin post-transplant, particularly if persistent or worsening, may indicate graft dysfunction. - Monitoring of prothrombin time and other coagulation parameters to assess for thrombotic events.

  • Differential Diagnosis:
    • - Hepatic Artery Stenosis: Distinguished by imaging focusing on arterial flow patterns and Doppler ultrasound findings. - Portal Vein Thrombosis: Identified by abnormal portal venous flow on imaging and elevated portal venous pressure. - Biliary Complications: Characterized by jaundice, elevated conjugated bilirubin, and imaging showing biliary tree abnormalities.

    (Evidence: Moderate) 13

    Management

    Initial Management

  • Surgical Revision: Early surgical intervention is often necessary for confirmed stenosis or thrombosis. Techniques include:
    • - Diamond-shaped Patch Technique: Utilizing a D-patch from recipient hepatic vein to reinforce the anastomosis, reducing stenosis risk 1. - Venoplasty and Stenting: Balloon angioplasty with or without stent placement to relieve stenosis and maintain patency 1.

    Medical Management

  • Anticoagulation: Prophylactic anticoagulation with heparin or low molecular weight heparin to prevent thrombosis, adjusted based on coagulation profiles 1.
  • Monitoring: Regular Doppler ultrasonography and CT angiography to monitor graft patency and detect early signs of complications.

    • Refractory Cases

  • Specialist Referral: Escalation to vascular or transplant surgeons for complex reconstructions or recurrent stenosis.
  • Advanced Interventions: Consideration of endovascular interventions or repeat surgical revisions as needed 1.

    • Contraindications:

  • Active bleeding or coagulopathy precluding surgical intervention.
  • Severe systemic illness compromising patient stability for surgery.

    • (Evidence: Moderate) 15

    Complications

    Acute Complications

  • Graft Thrombosis: Rapid onset of graft dysfunction, requiring urgent surgical or endovascular intervention.
  • Stenosis: Gradual narrowing of the anastomosis, leading to venous congestion and impaired graft function.

    • Long-term Complications

  • Chronic Venous Congestion: Persistent elevated central venous pressures, contributing to graft failure over time.
  • Recurrent Stenosis: Recurrent episodes necessitating repeated interventions, impacting graft longevity.

    • Management Triggers:

  • Elevated liver enzymes persistently above baseline.
  • Imaging evidence of venous outflow obstruction.
  • Clinical signs of graft dysfunction or portal hypertension exacerbation.

    • (Evidence: Moderate) 13

    Prognosis & Follow-up

    The prognosis for patients undergoing LDLT with optimized HV-RA anastomosis is generally favorable, with graft survival rates improving with advancements in surgical techniques. Key prognostic indicators include:
  • Initial Patency: Early patency of the HV-RA anastomosis significantly correlates with long-term graft survival.
  • Graft Regeneration: Effective regeneration assessed via CT volumetry at 1 week post-transplant.
  • Postoperative Complications: Absence or timely management of complications like stenosis or thrombosis.

    • Recommended Follow-up:

  • Short-term: Weekly to biweekly monitoring for the first month, focusing on liver function tests and imaging.
  • Long-term: Regular intervals (3-6 months initially, then annually) for imaging and biochemical assessments to ensure sustained graft function and detect early signs of complications.

    • (Evidence: Moderate) 13

    Special Populations

    Pediatric Patients

    In pediatric LDLT, the challenges of HV-RA anastomosis are compounded by smaller graft sizes and developing anatomy. Specialized techniques, such as meticulous patching and possibly using smaller, more flexible stents, are crucial to prevent stenosis and ensure adequate outflow.

    Elderly Patients

    Elderly recipients often have comorbid conditions that complicate postoperative management. Careful selection of graft size relative to recipient body habitus and meticulous surgical technique are paramount to minimize complications and optimize outcomes.

    Comorbidities

    Patients with pre-existing cardiovascular or coagulation disorders require tailored anticoagulation strategies and close monitoring to prevent thrombotic events post-transplant.

    (Evidence: Moderate) 13

    Key Recommendations

  • Use Diamond-shaped Patch Technique for RHV reconstruction to reduce the risk of stenosis 1. (Evidence: Strong)
  • Routine Postoperative Imaging including Doppler ultrasonography and CT angiography to monitor graft patency and venous outflow 13. (Evidence: Strong)
  • Early Intervention for Stenosis: Perform venoplasty or stenting promptly upon diagnosis of significant stenosis to maintain graft function 1. (Evidence: Moderate)
  • Prophylactic Anticoagulation in the immediate postoperative period to prevent thrombosis 1. (Evidence: Moderate)
  • Regular Follow-up Monitoring with biochemical markers and imaging to detect early signs of graft dysfunction 13. (Evidence: Moderate)
  • Tailored Management for Special Populations, considering age, comorbidities, and graft-to-recipient size ratios 13. (Evidence: Moderate)
  • Surgical Expertise and Experience are critical in minimizing complications; centers should have robust experience in LDLT procedures 1. (Evidence: Expert opinion)
  • Patient Selection Criteria should rigorously assess GRWR and potential for graft regeneration to optimize outcomes 2. (Evidence: Moderate)
  • Multidisciplinary Approach involving surgeons, radiologists, and hepatologists for comprehensive patient care 13. (Evidence: Expert opinion)
  • Continuous Education and Technique Refinement for surgical teams to adapt to evolving best practices in LDLT 1. (Evidence: Expert opinion)

    • References

    1 Lee TB, Choi BH, Yang KH, Ryu JH, Park YM, Chu CW. Diamond-shaped patch technique for right hepatic vein reconstruction in living-donor liver transplant: A simple method to prevent stenosis. Medicine 2018. link 2 Kamei H, Fujimoto Y, Nagai S, Suda R, Yamamoto H, Kiuchi T. Impact of non-congestive graft size in living donor liver transplantation: new indicator for additional vein reconstruction in right liver graft. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007. link 3 Kim DG, Moon IS, Kim SJ, Lee YJ, Lee MD. Effect of middle hepatic vein reconstruction in living donor liver transplantation using right lobe. Transplantation proceedings 2006. link 4 Tan F, Chen Z, Zhao Y, Liang T, Li J, Wei J. Novel technique for suprahepatic vena cava reconstruction in rat orthotopic liver transplantation. Microsurgery 2005. link 5 Malago M, Molmenti EP, Paul A, Nadalin S, Lang H, Radtke A et al.. Hepatic venous outflow reconstruction in right live donor liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005. link

    Original source

    1. [1]
      Diamond-shaped patch technique for right hepatic vein reconstruction in living-donor liver transplant: A simple method to prevent stenosis. — Lee TB, Choi BH, Yang KH, Ryu JH, Park YM, Chu CW Medicine (2018)
    2. [2]
      Impact of non-congestive graft size in living donor liver transplantation: new indicator for additional vein reconstruction in right liver graft. — Kamei H, Fujimoto Y, Nagai S, Suda R, Yamamoto H, Kiuchi T Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2007)
    3. [3]
      Effect of middle hepatic vein reconstruction in living donor liver transplantation using right lobe. — Kim DG, Moon IS, Kim SJ, Lee YJ, Lee MD Transplantation proceedings (2006)
    4. [4]
      Novel technique for suprahepatic vena cava reconstruction in rat orthotopic liver transplantation. — Tan F, Chen Z, Zhao Y, Liang T, Li J, Wei J Microsurgery (2005)
    5. [5]
      Hepatic venous outflow reconstruction in right live donor liver transplantation. — Malago M, Molmenti EP, Paul A, Nadalin S, Lang H, Radtke A et al. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2005)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG